Freeze-drying (lyophilization) explained
How the pharmaceutical industry removes water from vaccines, antibiotics and biologics to keep them stable, step by step.
VALREXA Biosciences · 7 min read · November 2026
- Freeze-drying removes water by turning ice directly into vapor under vacuum.
- It has three stages: freezing, primary drying and secondary drying.
- It is used for many vaccines, antibiotics and biologic medicines because water drives chemical breakdown.
Why remove water?
Many medicines are unstable in water. Water allows chemical reactions that slowly break molecules down, such as hydrolysis, and lets molecules move and clump together. Removing it can extend shelf life from days to years and make storage and shipping easier. Freeze-drying is used for many vaccines, antibiotics such as some cephalosporins, and biologic medicines including antibodies and other proteins.
The physics: sublimation
At low pressure, ice can turn straight into water vapor without melting, a process called sublimation. Freeze-drying exploits this: the product is frozen, then the pressure is lowered so ice sublimates away while the product stays frozen and keeps its structure.
The three stages
| Stage | What happens | Why it matters |
|---|---|---|
| 1. Freezing | The liquid formulation is cooled until fully solid, often to −40 °C or below. | Forms the ice crystals that will later be removed. Freezing rate affects crystal size and drying speed. |
| 2. Primary drying | Pressure is lowered to a deep vacuum and shelves are gently warmed. Ice sublimates and the vapor is captured on a very cold condenser. | Removes most of the water, typically the longest stage, often lasting a day or more. |
| 3. Secondary drying | Temperature is raised further to remove water bound to the product. | Brings residual moisture down to low levels, often a few percent or less. |
The critical temperature
Each formulation has a collapse temperature. If the product warms above it during primary drying, the dried structure can slump or melt back, giving a shrunken, sticky “cake” and a less stable product. Engineers design the drying cycle to stay safely below it.
Excipients: the helpers
| Type | Purpose | Common examples |
|---|---|---|
| Bulking agents | Give the dried cake structure | Mannitol, glycine |
| Lyoprotectants | Protect proteins by replacing water around them | Sucrose, trehalose |
| Buffers | Hold the pH steady | Phosphate, histidine, citrate |
| Surfactants | Reduce clumping at surfaces | Polysorbate 80 |
The finished product
The result is a dry, porous solid called a cake, usually sealed in a vial under vacuum or inert gas such as nitrogen. Before use, a pharmacist or clinician reconstitutes it with a specified sterile liquid according to the product’s approved label.
Quality checks on freeze-dried medicines
- Residual moisture, commonly measured by Karl Fischer titration.
- Cake appearance: no collapse, cracking or melt-back.
- Reconstitution time and clarity of the resulting solution.
- Potency, purity and identity of the active ingredient (see HPLC and quality testing).
- Sterility and endotoxins, since the process must be done aseptically.
- Container closure integrity: the seal keeps moisture and microbes out.
Regulation
Freeze-dried medicines in the U.S. are made under the FDA’s current Good Manufacturing Practice (cGMP) rules, and the FDA has published guidance on inspecting lyophilization processes. Because freeze-drying is done in open vials before sealing, it must take place in sterile, controlled cleanrooms.
Further reading
- FDA: Guide to inspections of lyophilization of parenterals
- FDA: Current Good Manufacturing Practice regulations
- USP: Standards and quality resources
These are authoritative background resources rather than citations to a specific experimental finding. This guide is educational, not medical advice, and does not endorse the use of experimental compounds.
